Quaker Houghton Q1 sales fall 6% to $442.9 million; net income down to $12.9 million
Quaker Houghton reported first-quarter 2025 net sales of $442.9 million, down about 6% from $469.8 million a year earlier, and net income of $12.9 million, or $0.73 per diluted share, versus $35.2 million, or $1.95, in the prior-year quarter. Management said it expects revenue and earnings in 2025 to be in line with 2024, citing ongoing weak end-market demand and tariff uncertainty.
Key points
- Net sales were $442.9 million, down about 6% from $469.8 million, with sales volumes down 3%.
- Net income was $12.9 million, or $0.73 per diluted share, versus $35.2 million, or $1.95; non-GAAP earnings per diluted share were $1.58 versus $2.09.
- Adjusted EBITDA was $69.0 million, down 17% from $83.3 million, and net cash used by operating activities was $3.1 million versus $27.2 million provided a year earlier.
- The company acquired Dipsol Chemicals for about $155.2 million in April 2025, funded with borrowings under its existing credit facility.
The filing
Written by AI on Nov 8, 2026, 1:49 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 01, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.